Giapreza 2.5 mg/ml concentrate for solution for infusion, SODIUM CHLORIDE SOLUTION 0.9%
CRH07
Phase 3 small_molecule active
Quick answer
Giapreza 2.5 mg/ml concentrate for solution for infusion, SODIUM CHLORIDE SOLUTION 0.9% for refractory hypotension in distributive shock is a Phase 3 program (small_molecule) at PAION Pharma GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- PAION Pharma GmbH
- Indication
- refractory hypotension in distributive shock
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active